This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: The Innovations of Daniel M Tal
Introduction
Daniel M Tal is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of medical science, particularly in the development of selective inhibitors for Na,K-ATPase. With a total of 3 patents to his name, Tal's work has the potential to impact treatments for various health conditions.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure." This patent describes alpha2-selective Na,K-ATPase inhibitors and prodrugs characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative. The applications of this invention are particularly relevant in lowering intraocular pressure and treating conditions such as glaucoma and heart diseases.
Career Highlights
Daniel M Tal is associated with Yeda Research and Development Co. Ltd., where he continues to innovate and contribute to scientific advancements. His work is recognized for its potential to improve therapeutic options in the medical field.
Collaborations
Tal has collaborated with notable colleagues, including Steven J D Karlish and Adriana Katz, enhancing the scope and impact of his research.
Conclusion
Daniel M Tal's contributions to the field of medical science through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile